Upregulation of PTPN1 aggravates endotoxemia-induced cardiac dysfunction through inhibiting mitophagy

Qixiang Song1, Heng Ma1, Lili Zhu1

  • 1Department of Pathophysiology, School of Basic Medical Science, Central South University, 110 Xiangya Road, Changsha 410083, China; Key Laboratory of Sepsis Translational Medicine of Hunan, Central South University, 110 Xiangya Road, Changsha 410083, China.

PubMed
Abstract

Insights

Protein tyrosine phosphatase non-receptor type 1 (PTPN1) worsens sepsis-induced heart dysfunction by blocking mitophagy. Inhibiting PTPN1 may treat endotoxemia by restoring mitophagy and cardiac function.

Area of Science:

  • Cardiovascular Biology
  • Mitochondrial Biology
  • Sepsis Pathophysiology

Background:

  • Sepsis can cause cardiac dysfunction and mitochondrial damage.
  • Mitophagy, the selective degradation of damaged mitochondria, plays a protective role.
  • The role of protein tyrosine phosphatase non-receptor type 1 (PTPN1) in sepsis-induced mitophagy is unclear.

Purpose of the Study:

  • To investigate PTPN1's role in mitophagy during sepsis.
  • To elucidate the mechanisms underlying PTPN1's effect on mitophagy.
  • To evaluate PTPN1 inhibitors as a therapy for endotoxemia-induced cardiac dysfunction.

Main Methods:

  • Endotoxemia model induced by lipopolysaccharide (LPS) in mice.
  • Evaluation of PTPN1 inhibitor Claramine (CLA) efficacy.
  • Assessment of mitochondrial function, mitophagy markers, and protein expression.
  • In vitro studies using H9c2 cardiomyocytes and STAT3 pathway analysis.

Main Results:

  • CLA treatment improved cardiac function and mitochondrial health in endotoxemic mice.
  • PTPN1 upregulation impaired mitophagy and worsened mitochondrial injury in cardiomyocytes.
  • PTPN1 interacted with STAT3, reducing its phosphorylation and inhibiting PINK1/PRKN transcription.
  • STAT3 directly regulated PINK1 and PRKN transcription via promoter binding.

Conclusions:

  • PTPN1 exacerbates cardiac dysfunction in endotoxemia by inhibiting mitophagy.
  • This inhibition occurs via STAT3 dephosphorylation and reduced PINK1/PRKN transcription.
  • Targeting PTPN1 offers a potential therapeutic strategy for sepsis-induced cardiac dysfunction.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.7K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K